Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31,604,526
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
36,901,564
-
Shares change
-
+5,386,377
-
Total reported value, excl. options
-
$602,550,993
-
Value change
-
+$85,027,216
-
Put/Call ratio
-
71%
-
Number of buys
-
88
-
Number of sells
-
-69
-
Price
-
$16.33
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q1 2020
180 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q1 2020.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36,901,564 shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (5,103,966 shares), BlackRock Inc. (2,497,426 shares), EVENTIDE ASSET MANAGEMENT, LLC (2,427,976 shares), Camber Capital Management LP (2,000,000 shares), FRANKLIN RESOURCES INC (1,829,772 shares), VANGUARD GROUP INC (1,699,660 shares), RENAISSANCE TECHNOLOGIES LLC (1,586,618 shares), PERCEPTIVE ADVISORS LLC (1,551,722 shares), Rubric Capital Management LP (1,213,412 shares), and Rock Springs Capital Management LP (1,175,000 shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.